These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1803607

  • 1. [Immunological and metabolic disorders and the means for their correction in patients with chronic bronchitis].
    Sil'vestrov VP, Kinitin AV, Chesnokova IV.
    Ter Arkh; 1991; 63(12):7-11. PubMed ID: 1803607
    [Abstract] [Full Text] [Related]

  • 2. [Correction of metabolic and immunologic disorders in chronic bronchitis with piracetam].
    Nikitin AV, Chesnokova IV, Sysoeva LI.
    Sov Med; 1990; (3):70-2. PubMed ID: 2367905
    [No Abstract] [Full Text] [Related]

  • 3. [The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
    Nikitin AV, Chesnokova IV, Sysoeva LI.
    Vrach Delo; 1990 Nov; (11):17-8. PubMed ID: 2098971
    [Abstract] [Full Text] [Related]

  • 4. [The clinico-immunological evaluation of the ribomunyl treatment of chronic bronchitis patients].
    Borisova AM, Khoroshilova NV, Pinegin BV, Eremina OF, Simonova AV, Kulakov AV, Golubeva NM, Dykhanov II.
    Ter Arkh; 1994 Nov; 66(3):46-50. PubMed ID: 8202852
    [Abstract] [Full Text] [Related]

  • 5. [Treatment methods in chronic bronchitis].
    Mal'tseva NM, Borisova AM, Kuznetsov VP, Sorokin AM.
    Ter Arkh; 1986 Nov; 58(12):108-11. PubMed ID: 3824202
    [Abstract] [Full Text] [Related]

  • 6. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
    Borisova AM, Novikova TA, Glazko AV.
    Ter Arkh; 1984 Nov; 56(10):29-31. PubMed ID: 6335306
    [Abstract] [Full Text] [Related]

  • 7. [Immunological disorders in chronic bronchitis].
    Makarevich AE, Danilov IP, Murzenok PP.
    Klin Med (Mosk); 1990 Oct; 68(10):44-7. PubMed ID: 2077277
    [Abstract] [Full Text] [Related]

  • 8. [The efficacy of membrane-stabilizing therapy in patients with chronic obstructive bronchitis].
    Prozorova GG, Sil'vestrov VP, Simvolokov SI, Nikitin AV.
    Ter Arkh; 1997 Oct; 69(10):34-6. PubMed ID: 9471786
    [Abstract] [Full Text] [Related]

  • 9. [A clinico-epidemiological study on the efficacy of thymopentin therapy in patients with chronic bronchitis and cellular immunity deficiency].
    Amoroso A, Di Rosa R, Guidotti G, Ferri GM, Afeltra A.
    Recenti Prog Med; 1990 Jan; 81(1):29-32. PubMed ID: 2236822
    [Abstract] [Full Text] [Related]

  • 10. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
    Iangolenko VV.
    Ter Arkh; 1991 Jan; 63(10):60-3. PubMed ID: 1725225
    [Abstract] [Full Text] [Related]

  • 11. [Changes in the clinico-functional and immunological indices of chronic obstructive bronchitis patients as affected by interferon and levamisole].
    Parashchak AP, Pertsovich LI.
    Probl Tuberk; 1987 Jan; (10):38-41. PubMed ID: 3422951
    [No Abstract] [Full Text] [Related]

  • 12. [In vitro studies of cellular immunity in chronic bronchitis with and without corticosteroid medication].
    Schönfeld N, Remy N, Bartmann P, Wahn U, Loddenkemper R.
    Pneumologie; 1992 May; 46(5):179-82. PubMed ID: 1615002
    [Abstract] [Full Text] [Related]

  • 13. [The pathogenesis of a broncho-obstructive syndrome in patients with chronic bronchitis].
    Novozhenov VG, Belonogov MA, Man'kov IuU, Kolomoets NM, Teselkin IuO, Popova NS.
    Klin Med (Mosk); 1995 May; 73(3):40-4. PubMed ID: 8577106
    [Abstract] [Full Text] [Related]

  • 14. [Chronic obstructive bronchitis: its pathogenetic aspects and the characteristics of its clinical course].
    Novozhenov VG, Belonogov MA, Teselkin IuO, Kolomoets NM, Prishchepov IA, Terent'ev VA, Kuleshova LS.
    Ter Arkh; 1996 May; 68(3):58-62. PubMed ID: 8744108
    [Abstract] [Full Text] [Related]

  • 15. [The clinico-immunological efficacy of the likopid treatment of chronic bronchitis patients].
    Borisova AM, Setdikova NKh, Pinegin BV, Kulakov AV, Golubeva NM.
    Ter Arkh; 1998 May; 70(3):38-40. PubMed ID: 9575587
    [Abstract] [Full Text] [Related]

  • 16. [Pathogenesis of tolylene diisocyanate intoxication].
    Osipova TV, Litovskaia AV, Vasil'eva TV, Egorova IV, Feklina TIu, Vifleemskiĭ AB.
    Gig Sanit; 2000 May; (5):22-5. PubMed ID: 11030104
    [Abstract] [Full Text] [Related]

  • 17. [Cellular and humoral immunity in patients with chronic bronchitis and hereditary variants of alpha 1-proteinase inhibitor].
    Serdiuk TM, Grinevich LI.
    Vrach Delo; 1991 Jan; (1):42-4. PubMed ID: 2011890
    [Abstract] [Full Text] [Related]

  • 18. [Immunological reactivity of patients with chronic obstructive bronchitis].
    Pokhodzeĭ IV, Sukhovskaia OA, Kulikov VD.
    Ter Arkh; 1988 Jan; 60(3):38-42. PubMed ID: 3388271
    [Abstract] [Full Text] [Related]

  • 19. [The abnormality of immune status and its correction in patients with chronic pancreatitis].
    Suleĭmanov SF.
    Vopr Pitan; 2008 Jan; 77(5):45-8. PubMed ID: 19048888
    [Abstract] [Full Text] [Related]

  • 20. [Effects of halotherapy on free radical oxidation in patients with chronic bronchitis].
    Farkhutdinov UR, Abdrakhmanova LM, Farkhutdinov RR.
    Klin Med (Mosk); 2000 Jan; 78(12):37-40. PubMed ID: 11210350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.